Carnegie Investment Counsel’s Xilinx Inc XLNX Stock Holding History

Carnegie Investment Counsel’s Portfolio XLNX Stock Details XLNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,999	Closed	-$636K	–	521
2021 Q4	$636K	Sell	2,999 -74	-2%	-$14.6K	0.02%	327
2021 Q3	$464K	Buy	3,073 +1,523	+98%	+$223K	0.02%	329
2021 Q2	$224K	Buy	+1,550	New	+$197K	0.01%	441
2021 Q1	–	Sell	-1,550	Closed	-$220K	–	471
2020 Q4	$220K	Buy	+1,550	New	+$202K	0.01%	400
2019 Q2	–	Sell	-1,641	Closed	-$208K	–	432
2019 Q1	$208K	Buy	+1,641	New	+$184K	0.01%	402

Other funds holding XLNX

PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

CGL

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

ACA

Atlas Capital Advisors Jackson, Wyoming $875M AUM

NEWAS

N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return

Carnegie Investment Counsel's XLNX Position: Q1 2022 in Review

Carnegie Investment Counsel sold out of Xilinx Inc (XLNX) in Q1 2022, closing a stake of 2,999 shares — an estimated $636K sold.

Carnegie Investment Counsel first reported a position in XLNX in Q1 2019 and held it in 5 quarters. The position peaked at $636K in Q4 2021. 4 funds tracked by Wall St. Rank hold XLNX as of Q1 2022.

Carnegie Investment Counsel reported no remaining Xilinx Inc position as of Q1 2022 after selling out during the quarter.
Carnegie Investment Counsel sold 2,999 Xilinx Inc shares in Q1 2022, an estimated $636K.
Carnegie Investment Counsel first reported a position in Xilinx Inc in Q1 2019 and held it in 5 quarters.
Carnegie Investment Counsel's Xilinx Inc position peaked at $636K in Q4 2021.
4 funds tracked by Wall St. Rank held Xilinx Inc as of Q1 2022.

Based on Carnegie Investment Counsel's 13F filing for Q1 2022, filed 11 Apr 2022.